2 studies found for:    20200024 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma
Condition: Thyroid Carcinoma
Interventions: Drug: Continuous pazopanib (Arm A);   Drug: Intermittent pazopanib (Arm B)
2 Completed Pazopanib in Treating Patients With Recurrent Glioblastoma
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Recurrent Adult Brain Tumor
Interventions: Drug: pazopanib hydrochloride;   Other: laboratory biomarker analysis

Indicates status has not been verified in more than two years